Trazodone - Solicitation

The Department of Defense, via DLA, is soliciting offers (SPE2D2‑26‑R‑0003) for a broad range of FDA‑cGMP‑compliant pharmaceutical products, including multiple strengths and package sizes of Triazodone tablets. Offerors must submit a single electronic copy of a Volume 1 Non‑Price Proposal and a Volume 2 Price Proposal through the Defense Logistics Agency Internet Bid Board System (DIBBS) by the closing date; all other submission methods are prohibited. Proposals must be in U.S. dollars, include a distinct eleven‑digit National Drug Code (NDC) for each item (the first five digits must identify the offeror), and identify whether the offeror is the manufacturer or a distributor, providing full manufacturing facility addresses for any foreign‑made products. Required documentation includes the completed SF 1449, technical requirements, past‑performance data, and compliance with all incorporated FAR/DFARS clauses (e.g., 52.204‑16, 52.204‑17, 52.204‑22, 52.209‑7, 52.209‑11, DFARS 252.204‑7019) as well as the cost‑recovery fee and quarterly sales‑reporting provisions. Evaluation will be based on technical acceptability and the lowest evaluated aggregate price, with the award to the responsible offeror meeting all terms of the Statement of Work and solicitation.

Notice ID

576bbb0e55014cfcad8358f66a94c66d

Solicitation Number

SPE2D2-26-R-0003

NAICS Code

325412

Classification Code

6505